Healthcare >> CEO Interviews >> June 12, 2000
DR EDWIN MOSES is the Executive Chairman of Oxford Asymmetry
International Plc. Dr Moses was awarded a first class Honours Degree
and Ph.D. in Chemistry from Sheffield University during the period 1973
to 1979. He was awarded a Royal Society/ NATO postdoctoral fellowship
for studies in biophysical chemistry at Regensburg University in
Germany. From 1981 to 1987, Dr Moses held a series of Sales and
Marketing positions for first Bethesda Research Laboratories (Germany)
and then Amersham International Plc (England) for culminating in the
position of European Marketing Manager. In 1987, he was appointed
Business Development Manager at Biotal Ltd, in Wales. In 1988, he moved
to Enzymatix Ltd initially as Business Development Manager followed by
promotion to Sales and Marketing Director one year later. Dr Moses was
headhunted from Enzymatix in 1991 and was appointed Commercial Director
of Raggio-Italgene SpA in Italy. In 1993 Dr Moses returned to the UK to
take up the position of Managing Director (subsequently CEO) of Oxford
Asymmetry. Profile
Can you explain the birth of the company, give me a brief history, and
describe where the company is today?
Dr. Moses:
